NCT05574049View on ClinicalTrials.gov

Weight Loss, Blood Sugar and Blood Lipid Effects of Tetrahydrocannabivarin (THCV) Impregnated Mucoadhesive Strips

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

January 4, 2022

Primary Completion Date

May 4, 2022

Study Completion Date

May 4, 2022

Conditions
Metabolic SyndromeMorbid ObesityHypercholesterolemiaHyperglycemia
Interventions
DRUG

Tetrahydrocannabivarin

The subjects will take once daily oromucosal strip with intervention drug for 90 days.

OTHER

Placebo

The subjects will take once daily oromucosal strip with no drug on it for 90 days

Trial Locations (1)

33762

Hair and Scalp Clinic, Clearwater

All Listed Sponsors
lead

Medical Life Care Planners, LLC

OTHER

NCT05574049 - Weight Loss, Blood Sugar and Blood Lipid Effects of Tetrahydrocannabivarin (THCV) Impregnated Mucoadhesive Strips | Biotech Hunter | Biotech Hunter